UCSF
/ MDI Scientific Meetings Series
 Public
scientific meetings of the UCSF Molecular Design Institute address focused
topics in molecular design. Scientists from Corporate
Scholars Program member companies attend conferences organized by the
Institute without fee but must register.
Meetings are held at the UCSF Laurel Heights
Conference Center, which is set on a beautiful ten acre site with gardens,
a spectacular view of the city, and nearby shops and restaurants.
The center contributes to the vibrant style of the meetings, which include
poster sessions and informal discussion at breaks and meals. Outstanding
speakers and participants from academia and industry attend, including
students and faculty from UCSF.
Upcoming Meetings
are Posted
Chairs
and Speakers
1997 Meetings 1998
Meetings 1999 Meetings 2000
Meetings 2001-02 Meetings
Sponsors
1997
Meetings
Computational
Methods in Combinatorial Chemistry
UCSF MDI Conference
October 9, 1997
Organizing Chair: I.D. Kuntz
Speakers
and Panelists
David Floyd, Bristol-Myers Squibb
Jon Ellman, University of California
Berkeley
Simon Kearsley, Merck Research Laboratories
Atsuo Kuki, Alanex Corpotation
I.D. Kuntz, University of California
San Francisco
Eric Martin, Chiron Corporation
Mark Murcko, Vertex Pharmaceuticals
Diana Roe, Sandia National Laboratories
Ray Salemme, 3D Pharmaceuticals
Yax Sun, Bristol-Myers Squibb
Will Welch, Arris Pharmaceuticals
Peter Willett, University of Sheffield
top
1998
Meetings
Molecular
Recognition in Drug Design: Docking and Scoring
UCSF MDI Conference
February 6-7, 1998
Sponsored by UCSF Department of Pharmaceutical
Chemistry and UCSF Molecular Design Institute
Organizing Chair: Peter Kollman
Speakers
Joshua Boger, Vertex Pharmaceuticals
Jeff Blaney, Metaphorics
Fred Cohen, University of California
San Francisco
Chris Culberson, Merck
Ken Dill, University of California
San Franicsco
Barry Honig, Columbia University
Ajay Jain
Peter Kollman, University of California
San Francisco
I.D. Kuntz, University of California
San Francisco
Mill Lambert, Glaxo Wellcome
Andrew Leach, Glaxo Wellcome
Thomas Lengauer, GMD-German National
Research Center for Information Technology
Peter Grootenhuis, NV Organon
Pieter Stouten, DuPont Merck
Gennady Verkhivker, Agouron Pharmaceuticals
Pat Walters, Vertex Pharmaceuticals
Mechanisms
of Tumor Growth and Invasion Mediated by Proteolysis
UCSF MDI Conference
November 5-6, 1998
Organizing Chairs: Marc
Shuman, Charles
Craik, Jim McKerrow
and Zena Werb
Speakers
Alfred L. Goldberg, Harvard Medical
School
Krzysztof Appelt, Agouron Pharmaceuticals
Roy A. Black, Immunex Corp.
John Cheronis, Cortech, Inc.
Jerry Collins, FDA
Lisa Coussens, University of California
San Francisco
Charles Craik, University of California
San Francisco
Jon Ellman, University of California
Berkeley
Doug Hanahan, University of California
San Francisco
Frank McCormick, University of California
San Francisco
James McKerrow, University of California
San Francisco
Bonnie Sloane, Wayne State University
Marc Shuman, University of California
San Francisco
Nancy Thornberry, Merck
Zena Werb, University of California
San Francisco
Rusty Williams, Chiron Corporation
top
1999
Meetings
Structure
and Design of Synthetic Gene Carriers
UCSF MDI Conference
February 24-26, 1999
Sponsored by UCSF Molecular Design Institute
and UCSF Cystic Fibrosis Research Development Program with support from
UC Systemwide Biotechnology Research and Education Program
Organizing Chairs: Frank
Szoka , Philip Felgner
, and Leaf
Huang
Speakers
and Chairs
Eric Alton, Imperial College of Science
Technology & Medicine
Jean Paul Behr, Centre National de
la Recherche Scientifique
Vladimir Budker, University of Wisconsin
Hermann Bujard, ZMBH, University of
Heidelberg
Robert Debs, California Pacific Medical
Research Institute
Ken Dill, University of California
San Francisco
Nejat Duzgunes, University of the Pacific
Philip Felgner, Gene Therapy Systems
Todd D. Giorgio, Vanderbilt University
Dieter Gruenert, University of California
San Francisco
Zach Hall, University of California
San Francisco
Evan M. Hersh, Arizona Cancer Center
Leaf Huang, University of Pittsburgh
Alexander Kabanov, University of Nebraska
Medical Center
Y.W. Kan, University of California
San Francisco
Yasufumi Kaneda, Osaka University School
of Medicine
David Klatzmann, Universite Pierre
et Marie Curie
Eric B. Kmiec, Thomas Jefferson University
Peter Kollman, UCSF-MDI
Philip L. Leopold, The New York Hospital/Cornell
Medical Center
Gergely L. Lukacs, Hospital for Sick
Children Research Institute
David H. Kirn, Onyx Pharmaceuticals
Donald McDonald, University of California
San Francisco
Jeffrey Nordstrom, GeneMedicine
Cyrus Safinya, UC-Santa Barbara
Nadrian C. Seeman, New York University
Brigette Sternberg-Papahadjopoulos, California
Pacific Medical Research Institute
Terry Stouch, Bristol-Myers Squibb
Frank Szoka, UCSF-MDI
Alan Verkman, University of California
San Francisco
Jean Michel Vos, University North Carolina
Chapel Hill
John A. Wagner, Merck Research Laboratories
Winfried Wels, Chemotherapeutisches
Forschungsinstitut Georg-Speyer-Haus
Ronald Zuckermann, Chiron Corporation
Dock:
Applied Structure-Based Drug Design
1999
User Group Meeting
UCSF MDI Conference
April 16-17, 1999
Chair: I.D. Kuntz
Protein
Sequence Structure Function
UCSF MDI Conference
April 23-24, 1999
Sponsored by UCSF Department of Pharmaceutical
Chemistry and UCSF Molecular Design Institute
Organizing Chairs: Peter
Kollman, Ken Dill
and
I.D. Kuntz
Speakers
Patsy Babbitt, UCSF
David Baker, University of Washington
Marvin Cassman, NIH
Ken Dill, UCSF
David Eisenberg, UCLA
Chris Fields, Molecular Informatics
Sung-Hou Kim, UC Berkeley
Peter Kollman, UCSF
Irwin Kuntz, UCSF
Michael Levitt, Stanford
Steve Mayo, California Institute of
Technology
Brian Metcalf, SmithKline Beecham
Andrej Sali, Rockefeller University
Chris Sander, Millennium Pharmaceuticals
David Searls, SmithKline Beecham
David Spellmeyer, CombiChem
top
2000
Meetings
Drug
Design and Discovery
UCSF/MDI Symposium
October 13-14, 2000
Sponsored by UCSF Department of Pharmaceutical
Chemistry and UCSF Molecular Design Institute
Organizing Chairs: Peter Kollman, Ken Dill
and Irwin Kuntz
Speakers
Johan Aqvist,
Uppsala
University
Paul Anderson,
Dupont
Pharmaceuticals
Ken Dill, University
of California San Francisco
David Diller,
Pharmacopeia
Robert Fletterick,
University
of California San Francisco
Simon Kearsley,
Merck
Research Laboratories
Peter Kollman,
University
of California San Francisco
Irwin Kuntz, University
of California San Francisco
Robert McDowell,
Sunesis
Jon Mason, Bristol
Myers Squibb
David Pearlman,
Vertex
Pharmaceuticals
Tom Scanlan, University
of California San Francisco
Bruce Tidor,
Massachusetts
Institute of Technology
Dennis Underwood,
DuPont
Pharmaceuticals
Gennady Verkhivker,
Agouron
Pharmaceuticals
Year
2000 DOCK User Group Meeting
UCSF MDI Conference
October 15-16, 2000
Chair: I.D. Kuntz
top
2001
Meeting
Year
2001 DOCK User Group Meeting
Introducing
DOCK5
UCSF MDI Conference
November 2-3, 2001
Chair: I.D. Kuntz
top
2002
Meeting
Molecular
Simulations in Structural Biology and Drug Discovery
Symposium Honoring Peter A. Kollman
February 21-22, 2002
Sponsored by the UCSF Department of Pharmaceutical
Chemistry and UCSF Molecular Design Institute and co-sponsored by the Biophysical
Society
Organizing Chairs: Ken Dill, Thomas Cheatham,
and Kennie Merz
|
